Athenex is a global oncology focused biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, aiming to develop safer and more efficacious cancer medication.
Founded in 2003 and based in Buffalo, New York, our mission is to improve the lives of cancer patients by creating more effective, safer and tolerable treatments. We are focused on generating clinical candidates focused on oral delivery, and currently have seven products including two currently in Phase 3 studies. Read more »
Athenex Provides a Corporate Update